By The Rio Times | Created at 2026-08-14 16:41:43 | Updated at 2026-08-14 17:48:19
1 hour ago
Brazil · Earnings
Key Facts
- —The profit Yduqs booked adjusted net income of R$14 million (about US$2.7 million) in Q2 2026, down 54.2% from a year earlier.
- —The reported line Without adjustments, the group swung to a net loss of R$1.5 million (roughly US$0.3 million), reversing a small profit in Q2 2025.
- —The drag Its distance-learning student base fell 6.9%, and the online undergraduate base sank 18.3% after Brazil tightened the rules on remote courses.
- —The offset On-campus enrollment jumped 19.1%, and the Idomed medical arm posted record intake with first-half revenue of R$694 million (about US$134 million), up 9%.
- —The top line Net revenue rose 1% to R$1.4 billion (around US$270 million) and adjusted EBITDA edged up 1.6% to R$400.2 million (roughly US$77 million).
Fewer online students dragged on the quarter. Yet a booming medical arm and a swing to hybrid classrooms kept the operating engine running.
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Yduqs, one of Brazil’s largest higher-education groups, saw its adjusted profit fall by more than half in the second quarter of 2026. New federal limits on online courses thinned its distance-learning ranks, even as its on-campus and medical schools kept growing.
What Yduqs actually reported
The company posted adjusted net income of R$14 million, or about US$2.7 million, for the April-to-June quarter. That is a 54.2% drop from the same period a year earlier.
The result also came in well short of the market. Analysts had penciled in roughly R$29 million, so the miss was wide.
Why the Yduqs profit fell short
Most of the damage sat below the operating line. High interest rates in Brazil, with the benchmark Selic rate elevated, kept financial expenses heavy through the quarter.
As a result, healthy operations did not translate into a healthy bottom line. In short, the business earned steadily but handed much of it to lenders.
The reported figure was even weaker
Strip away the adjustments and the picture darkens further. On a reported basis, the group swung to a net loss of R$1.5 million, or roughly US$0.3 million.
That reversed a modest profit from a year earlier. Still, the sums involved are small, so the loss reflects timing and accounting more than a collapse in trade.
New rules squeeze distance learning
The clearest weak spot was online education, known locally as EAD. The distance-learning student base fell 6.9%, from 1.092 million to 1.016 million students.
The undergraduate slice dropped even harder, down 18.3% to 443,000. That is because a new regulatory framework now bars remote intake in engineering, health, and teaching-degree courses.
On-campus and medicine take up the slack
While online learning shrank, the physical classroom surged. The on-campus base climbed 19.1% to 380,000 students, helped by a rush into hybrid, or semipresencial, formats.
Hybrid enrollment alone jumped 66.6% year over year. Meanwhile, the Idomed medical arm booked its biggest-ever intake, with first-half revenue of R$694 million (about US$134 million), up 9%.
Revenue and margins held their ground
Despite the profit slide, the top line barely moved. Net revenue rose 1% to R$1.4 billion, or around US$270 million, as premium courses offset cheaper online ones.
Adjusted EBITDA, a gauge of core operating cash, edged up 1.6% to R$400.2 million (roughly US$77 million). The margin firmed to 28.7%, so day-to-day profitability actually improved.
The student headcount barely moved
Add it all up and the group’s total student base was remarkably stable. It slipped just 0.9%, from 1.432 million a year ago to 1.419 million.
In other words, the shift was about mix, not sheer size. Students migrated from pure online study toward hybrid and on-campus programs, which carry fatter margins.
How the market is reading it
Investors had braced for a soft quarter well before the release. In July, Citi cut its price target on the shares to R$11, or about US$2.12, flagging a tougher backdrop.
The stock trades on Brazil’s B3 exchange under the ticker YDUQ3. Because the profit missed forecasts, the report gave cautious analysts little reason to change their view.
What comes next for Yduqs
The near-term story hinges on interest rates and regulation. Lower financing costs would ease the pressure that hollowed out this quarter’s bottom line.
Longer term, the company is leaning on medicine and hybrid courses to replace lost online volume. Whether that pivot can lift profit again is the key question for the months ahead.
Frequently Asked Questions
How much did Yduqs profit fall in Q2 2026?
Yduqs reported adjusted net income of R$14 million, about US$2.7 million, down 54.2% from a year earlier. On a reported basis it swung to a small net loss of R$1.5 million.
Why did distance learning weigh on the results?
Brazil’s new regulatory framework now bars remote intake in engineering, health, and teaching-degree courses. That helped push the distance-learning student base down 6.9%, and the online undergraduate base fell 18.3%, as students shifted toward hybrid formats.
What offset the online decline?
On-campus enrollment rose 19.1%, hybrid enrollment jumped 66.6%. And the Idomed medical arm posted record intake with first-half revenue of R$694 million, up 9%.
How can I follow Yduqs shares?
Yduqs trades on Brazil’s B3 exchange under the ticker YDUQ3. Investors are watching interest-rate moves and the pace at which medicine and hybrid courses replace lost online enrollment.
Sources: InfoMoney; MoneyTimes; Valor Econômico; UOL Economia; Reuters.
